No abstract available
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Busulfan / adverse effects*
-
Carcinoma in Situ / pathology
-
Cyclophosphamide / adverse effects*
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Diagnosis, Differential
-
Female
-
Hematopoietic Stem Cell Mobilization
-
Hematopoietic Stem Cell Transplantation*
-
Humans
-
Leukemia, Monocytic, Acute / therapy*
-
Mitoxantrone / administration & dosage
-
Remission Induction
-
Thioguanine / administration & dosage
-
Transplantation, Autologous
-
Uterine Cervical Dysplasia / chemically induced*
-
Uterine Cervical Dysplasia / pathology*
Substances
-
Cytarabine
-
Cyclophosphamide
-
Mitoxantrone
-
Thioguanine
-
Busulfan
-
Daunorubicin